SOURCE: AstraZeneca

December 07, 2007 05:15 ET

ASTRAZENECA - Biologics Day interviews with senior management

LONDON--(Marketwire - December 7, 2007) -

David Brennan, AstraZeneca CEO, and senior management from AstraZeneca and MedImmune discuss opportunities in the biologics field, R&D and portfolio progress plus the Group's current focus and priorities. The interviews and transcripts are available now on

David Brennan, CEO, AstraZeneca
David Mott, CEO, MedImmune
Dr John Patterson, Development Director, AstraZeneca
Jim Young, Head of R&D, MedImmune

This programming is available in video, audio and transcript. It's free to view. All you need to do is register at . is an online financial website where top management of companies address the critical issues facing their businesses. If you would like to contact us, please email

Copyright © Hugin ASA 2007. All rights reserved.

Contact Information